ChemGenex Appoints Dr. Julie Cherrington to Board of Directors
- ChemGenex Pharmaceuticals ( ASX : CXS ) ( NASDAQ : CXSP ) today announced that Dr. Julie Cherrington, President of Phenomix ....
Tue Jan 2008 12:01 (1 year ago)
Reuters Africa
482 articles in collection
Reuters Africa
482 articles in collection
Related articles
11 months
after
after
- Australian Government, Department of Defence - Federal Government
7 months
after
after
- ChemGenex Appoints Jean-Luc Tetard to Board of Directors - PR-inside.com
- ChemGenex Appoints Jean-Luc Tetard to Board of Directors - centredaily.com
5 months
after
after
- ChemGenex Announces Submission of Non-Clinical Section of Rolling NDA for Omacetaxine - TradingMarkets.com
- ChemGenex Announces Submission of Non-Clinical Section of Rolling NDA for Omacetaxine - Business Wire
- ChemGenex's Omacetaxine Demonstrates Activity In CML Patients Who Have Failed Therapy With Multiple Tyrosine Kinase Inhibitors - Medical News TODAY
- ChemGenex?s Omacetaxine Demonstrates Activity in CML Patients Who Have Failed Therapy With Multiple Tyrosine Kinase Inhibitors - Lifescience online
- Jkureczka @ comcast. net ChemGenex Pharmaceuticals ( ASX : CXS ) ( NASDAQ : CXSP ) announced today ..." href="/like/chemgenex_acquires_full_control_of_omacetaxine_consolidating_the_products_global_rights/2078592/">ChemGenex Acquires Full Control of Omacetaxine, Consolidating the Product's Global Rights - PR-inside.com
- ChemGenex Acquires Full Control of Omacetaxine, Consolidating the Product's Global Rights - TradingMarkets.com
- ChemGenex Acquires Full Control of Omacetaxine, Consolidating the Product's Global Rights - StreetInsider.com
4 months
after
after
- ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation at ASCO - Business Wire
- Metabolic Pharmaceuticals appoints directors - Business Spectator appointments
2 months
after
after
- ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients With the T315I Mutation at International Leukemia Conference - Business Wire
- Alpha Technologies appoints directors - Business Spectator manufacturing
- Sims Group appoints directors - Business Spectator director ...
- Beaconsfield Gold appoints directors - Business Spectator resources ...
- Orbital Corp appoints directors - Business Spectator appointments
- Clinical Cell Culture appoints directors - Business Spectator appointments
1 month
after
after
- Gleneagle Gold appoints directors - Business Spectator resources ...
- Reports of the death of Work Choices are greatly exaggerated say unions - ACTU
3 weeks
before
before
4 weeks
before
before
1 month
before
before
- ChemGenex Appoints Donald Santel to Board of Directors - Business Wire
